Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Nu Skin
NUS
$236M
| $36.9M | 0.01% |
912,645
+52,515
| +6% | +$2.66M |
|
1077
HNI Corp
HNI
$3.55B
| $36.9M | 0.01% |
1,004,776
+97,198
| +11% | +$3.76M |
|
1078
Strategy Inc
MSTR
$37.3B
| $36.7M | 0.01% |
634,820
+6,670
| +1% | +$428K |
|
|
JBTM
1079
JBT Marel
JBTM
$6.15B
| $36.7M | 0.01% |
261,051
+5,222
| +2% | +$749K |
|
1080
Banner Corp
BANR
$2.5B
| $36.7M | 0.01% |
664,034
+40,598
| +7% | +$2.19M |
|
1081
Old Republic International
ORI
$10.3B
| $36.6M | 0.01% |
1,584,068
+36,463
| +2% | +$902K |
|
1082
Hanover Insurance
THG
$7.74B
| $36.5M | 0.01% |
281,833
+7,096
| +3% | +$966K |
|
1083
Ryder
R
$10.1B
| $36.3M | 0.01% |
439,165
-112,531
| -20% | -$8.66M |
|
|
SUM
1084
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $36.3M | 0.01% |
1,153,850
+1,196
| +0.1% | +$39K |
|
|
UMPQ
1085
DELISTED
Umpqua Holdings Corp
UMPQ
| $36.2M | 0.01% |
1,787,636
+12,760
| +0.7% | +$245K |
|
1086
OGE Energy
OGE
$9.69B
| $36.1M | 0.01% |
1,095,857
+36,896
| +3% | +$1.27M |
|
1087
Carlyle Group
CG
$17.2B
| $36.1M | 0.01% |
763,455
+151,558
| +25% | +$7.27M |
|
1088
Choice Hotels
CHH
$4.75B
| $36.1M | 0.01% |
285,336
+36,658
| +15% | +$4.38M |
|
1089
Sensient Technologies
SXT
$5.55B
| $35.9M | 0.01% |
394,570
+2,427
| +0.6% | +$213K |
|
1090
Commault Systems
CVLT
$5.87B
| $35.9M | 0.01% |
477,110
+87,811
| +23% | +$6.81M |
|
1091
TD Synnex
SNX
$20.4B
| $35.9M | 0.01% |
344,765
+22,640
| +7% | +$2.71M |
|
1092
Ionis Pharmaceuticals
IONS
$9.39B
| $35.9M | 0.01% |
1,069,732
+355,772
| +50% | +$13.4M |
|
1093
Applied Industrial Technologies
AIT
$13B
| $35.9M | 0.01% |
397,799
+4,785
| +1% | +$421K |
|
|
QVCGA
1094
DELISTED
QVC Group Inc Series A
QVCGA
| $35.8M | 0.01% |
70,241
-3,927
| -5% | -$2.21M |
|
1095
Flowserve
FLS
$10.3B
| $35.8M | 0.01% |
1,031,330
-25,082
| -2% | -$981K |
|
1096
Merit Medical Systems
MMSI
$5.45B
| $35.6M | 0.01% |
496,248
-17,513
| -3% | -$1.19M |
|
1097
Neogen
NEOG
$2.5B
| $35.6M | 0.01% |
818,904
+11,995
| +1% | +$522K |
|
1098
Toll Brothers
TOL
$13.9B
| $35.5M | 0.01% |
642,595
+31,490
| +5% | +$1.86M |
|
1099
Denali Therapeutics
DNLI
$4.04B
| $35.5M | 0.01% |
703,752
+63,518
| +10% | +$3.58M |
|
1100
Signet Jewelers
SIG
$3.59B
| $35.5M | 0.01% |
449,525
-29,083
| -6% | -$2.14M |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.